Key Segments:
By Phase
-
- Clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Preclinical
- Clinical
By Application
-
- Oncology
- Rare Diseases
- Infectious Diseases
- Others
By Service
-
- Contract Manufacturing
- Contact Development
By Type
-
- Inhibitor Drugs
- Monoclonal Antibodies
- Cell & Gene Therapy
- Others
By End Use
-
- Pharmaceutical Companies
- Biotechnology Companies
- Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
- US
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- ASEAN Countries
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- Egypt
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g., Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
- Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: North America dominated the personalized medicine outsourcing market in 2024.
Ans: The “clinical” segment dominated the personalized medicine outsourcing market.
Ans: The high cost and complex nature of personalized medicine R&D to be conducted in-house have accelerated the market growth.
Ans: The personalized medicine outsourcing market was USD 109.88 billion in 2024 and is expected to reach USD 281.72 billion by 2032.
Ans: The personalized medicine outsourcing market is expected to grow at a CAGR of 12.54% from 2025 to 2032.